Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Contact DCTD
Show menu
Search this site
Last Updated: 08/26/2020

Validated Assays, Specimen Handling Procedures and Reagent Sources for Poly-Adenosyl Ribose (PAR) Immunoassay

The PAR Immunoassay has been developed to measure the effect of PARP inhibitors and/or chemotherapeutic agents on PAR levels in a variety of biospecimen types, including peripheral blood mononuclear cells (PBMCs) and tumor biopsies.

Please email any questions or comments to